Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, Epiciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation
Journal articles

Proteomics and the blood–brain barrier: how recent findings help drug development

Abstract : The drug discovery and development processes are divided into different stages separated by milestones to indicate that significant progress has been made and that certain criteria for target validation, hits, leads and candidate drugs have been met. Proteomics is a promising approach for the identification of protein targets and biochemical pathways involved in disease process and thus plays an important role in several stages of the drug development. The blood-brain barrier is considered as a major bottleneck when trying to target new compounds to treat neurodegenerative diseases. Based on the survey of recent findings and with a projection on expected improvements, this report attempt to address how proteomics participates in drug development.
Document type :
Journal articles
Complete list of metadata
Contributor : Virginie Justin-Labonne Connect in order to contact the contributor
Submitted on : Tuesday, March 17, 2020 - 4:18:44 PM
Last modification on : Friday, January 21, 2022 - 3:30:01 AM




yannis Karamanos, Gwënaël Pottiez. Proteomics and the blood–brain barrier: how recent findings help drug development. Expert Review of Proteomics, Taylor & Francis, 2016, 13 (3), pp.251-258. ⟨10.1586/14789450.2016.1143780⟩. ⟨hal-02510297⟩



Record views